title: Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
abstract: BACKGROUND
  The pathogenesis of cirrhotic ascites and hepatorenal syndrome remains unresolved. The involvement of both endothelin-1 and atrial natriuretic peptide have recently been suggested. This study investigated the concentrations of serum endothelin and atrial natriuretic peptide in cirrhotic patients.
  
  
  METHODS
  Seven healthy subjects and 31 cirrhotic patients were studied. Cirrhotic patients were divided into three groups: Group I, 16 cirrhotic patients without ascites; Group II, 10 cirrhotic patients with ascites, but without hepatorenal syndrome; and Group III, five cirrhotic patients with hepatorenal syndrome and ascites. Their sera were analyzed for endothelin-1 and atrial natriuretic peptide concentrations.
  
  
  RESULTS
  Cirrhotic patients with ascites, Group II and Group III, had higher plasma endothelin-1 concentrations (15.9 +/- 2.3 pg/ml and 24 +/- 2.1 pg/ml, respectively) than normal subjects and compensated cirrhotics (3.8 +/- 0.7 pg/ml and 6.4 +/- 1.1 pg/ml, respectively); p < 0.001). Atrial natriuretic peptide concentrations were also significantly higher in cirrhotic patients than in normal subjects (p < 0.025). Plasma endothelin-1 concentration had a negative correlation with creatinine clearance (r = -0.65, p < 0.001), as did atrial natriuretic peptide concentrations (r = -0.44, p = 0.012). Plasma endothelin-1 correlated significantly with atrial natriuretic peptide concentrations (r = 0.38, p = 0.035).
  
  
  CONCLUSIONS
  Both endothelin-1 and atrial natriuretic peptide concentrations were elevated in cirrhotic patients with ascites and hepatorenal syndrome. Endothelin-1 may have a negative impact on renal function. Our data also suggested that impaired responsiveness rather than impaired secretion of atrial natriuretic peptide is responsible for sodium retention in cirrhotic patients with ascites.
authors.affiliation: Department of Medicine, Veterans General Hospital-Kaohsiung, Taiwan, ROC.
authors.forename: G H
authors.initials: GH
authors.lastname: Lo
authors.forename: H C
authors.initials: HC
authors.lastname: Lam
authors.forename: J T
authors.initials: JT
authors.lastname: Cheng
authors.forename: J K
authors.initials: JK
authors.lastname: Lin
authors.forename: J H
authors.initials: JH
authors.lastname: Hsu
authors.forename: K H
authors.initials: KH
authors.lastname: Lai
authors.forename: H T
authors.initials: HT
authors.lastname: Chiang
mesh_terms: D000328:Adult; D000368:Aged; D001201:Ascites / Q000097:blood*; D009320:Atrial Natriuretic Factor / Q000097:blood*; D019332:Endothelin-1 / Q000097:blood*; D005260:Female; D006530:Hepatorenal Syndrome / Q000097:blood*; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood*; D008297:Male; D008875:Middle Aged
chemical_list: D019332:Endothelin-1; D009320:Atrial Natriuretic Factor